Cooper Companies (COO) Stock Overview
Develops, manufactures, and markets contact lens wearers. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for COO from our risk checks.
COO Community Fair Values
Create NarrativeSee what 28 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
The Cooper Companies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$71.50 |
| 52 Week High | US$89.83 |
| 52 Week Low | US$61.78 |
| Beta | 1.03 |
| 1 Month Change | -14.80% |
| 3 Month Change | -12.76% |
| 1 Year Change | -11.98% |
| 3 Year Change | -23.45% |
| 5 Year Change | -25.27% |
| Change since IPO | 826.99% |
Recent News & Updates
Recent updates
Moderating Growth Could Be A Tough Challenge For Cooper Shares
Feb 13Is It Too Late To Consider Buying The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 06
Some Investors May Be Worried About Cooper Companies' (NASDAQ:COO) Returns On Capital
Jul 21Market Participants Recognise The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Jul 03Is It Time To Consider Buying The Cooper Companies, Inc. (NASDAQ:COO)?
Jun 15Does Cooper Companies (NASDAQ:COO) Have A Healthy Balance Sheet?
May 30Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
May 14CooperCompanies: A Somewhat Less Demanding Valuation, But Some Added Growth Concerns
Mar 01The Cooper Companies: Winning Share In Contact Lens Markets
Oct 09
Innovative Growth In Myopia Management And Fertility Boosts Future Prospects
Expansion in manufacturing and new product introductions alongside strategic R&D investments in myopia and fertility are driving growth and margins.The Cooper Companies: Still An Expensive Place
Aug 26Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22The Cooper Companies: I Still Don't See Much Upside
Mar 01Shareholder Returns
| COO | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.07% | -1.3% | -0.6% |
| 1Y | -12.0% | -13.5% | 16.0% |
Return vs Industry: COO exceeded the US Medical Equipment industry which returned -15% over the past year.
Return vs Market: COO underperformed the US Market which returned 14% over the past year.
Price Volatility
| COO volatility | |
|---|---|
| COO Average Weekly Movement | 3.3% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: COO has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: COO's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.
The Cooper Companies, Inc. Fundamentals Summary
| COO fundamental statistics | |
|---|---|
| Market cap | US$13.95b |
| Earnings (TTM) | US$401.40m |
| Revenue (TTM) | US$4.15b |
Is COO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COO income statement (TTM) | |
|---|---|
| Revenue | US$4.15b |
| Cost of Revenue | US$1.43b |
| Gross Profit | US$2.72b |
| Other Expenses | US$2.32b |
| Earnings | US$401.40m |
Last Reported Earnings
Jan 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.06 |
| Gross Margin | 65.44% |
| Net Profit Margin | 9.67% |
| Debt/Equity Ratio | 29.9% |
How did COO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/01 07:39 |
| End of Day Share Price | 2026/03/31 00:00 |
| Earnings | 2026/01/31 |
| Annual Earnings | 2025/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Cooper Companies, Inc. is covered by 29 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jeffrey Johnson | Baird |
| Matthew Miksic | Barclays |
| Joanne Wuensch | BMO Capital Markets Equity Research |